表紙
市場調查報告書

全球軟骨修復和再生市場:按治療型態 (細胞/非細胞)、處理方法、應用的未來展望 (2020年)

Global Cartilage Repair and Regeneration Market, by Treatment Modalities (Cell-Based Approach, Non-Cell-Based Approach), by Procedure Type, by Application Outlook 2022

出版商 RNCOS E-Services Pvt. Ltd. 商品編碼 486150
出版日期 內容資訊 英文 90 Pages
訂單完成後即時交付
價格
全球軟骨修復和再生市場:按治療型態 (細胞/非細胞)、處理方法、應用的未來展望 (2020年) Global Cartilage Repair and Regeneration Market, by Treatment Modalities (Cell-Based Approach, Non-Cell-Based Approach), by Procedure Type, by Application Outlook 2022
出版日期: 2020年03月01日內容資訊: 英文 90 Pages
簡介

由於生活習慣的變化,導致肥胖及退化性關節疾病等疾病發生,這些因素直接或間接造成軟骨損傷。因此,預估全球軟骨修復和再生市場將在預期間中 (2016∼2022) 將達到兩位數的高成長率。治療形態方面,以基於細胞的治療占最大占比;處理方法方面以微骨折和ACI (自體培養軟骨細胞移植) 為最一般。應用方面,以透明軟骨占最大占比;區域方面,預估亞太地區可期快速市場成長。

本報告研究全球軟骨修復和再生市場,彙整技術和相關疾病概要、市場基本結構和最新情勢、主要市場推動和阻礙因素、市場規模趨勢展望 (共6年),提供按治療型態、處理方法、應用、區域的詳細動向,以及未來資本交易、市場成長機會、主要企業簡介、市場占比等情報。

第1章 分析師見解

第2章 分析方法

第3章 軟骨修復:概要

第4章 市場動態

  • 市場推動因素
    • 隨著軟骨營養不良發病率上升的軟骨損傷發生率增加
    • 骨科疾病發病率上升
    • 運動傷害激增
    • 老年人口的增加
    • 肥胖症盛行率上升
    • 技術進步
  • 課題
    • 開發中國家的健康保險範圍限制
    • 膝軟骨修復手術的高成本
    • 軟骨修復手術的複雜性
  • 市場機會
    • 由於第一選擇療法的滿意度低,為美國國內帶來重大市場機會
    • 新興國家的持續成長機會提供
    • 膝關節軟骨:伴隨研發支出增額的技術進步
    • 生物活性成長因素的利用
    • 3D列印

第5章 全球軟骨修復和再生市場未來展望

第6章 軟骨修復和再生市場:按治療型態

  • 基於細胞的方法
  • 基於非細胞的方法

第7章 全球軟骨修復和再生市場:按處理方法

  • 自體軟骨細胞移植 (ACI)
  • 基於細胞的軟骨置換
  • 微骨折
  • 骨軟骨同種異體移植物
  • 其他

第8章 全球軟骨修復和再生市場:按應用

  • 透明軟骨的修復和再生
  • 彈性軟骨的修復和再生
  • 纖維軟骨的修復和再生

第9章 全球軟骨修復和再生市場:按區域

  • 北美
  • 歐洲
  • 亞太地區

第10章 監管環境

第11章 市場趨勢和發展

  • One-Step手術:社會對成本效益的關心
  • 強化軟骨修復的生物活性訊號
  • 軟骨修復的基因治療
  • 間葉系幹細胞

第12章 競爭環境

  • 主要企業市場占比
  • 產品比較分析

第13章 主要企業分析

  • Stryker Corporation
  • B. Braun Melsungen AG
  • Zimmer Biomet Holdings、Inc.
  • Smith&Nephew plc
  • DePuy Synthes、Inc. (Johnson&Johnson子公司)
  • Arthrex、Inc.
  • Osiris Therapeutics、Inc.
  • Vericel Corporation
  • RTI Surgical、Inc.
  • CONMED Corporation
  • Anika Therapeutics、Inc.

第14章 軟骨修復市場未來樣貌

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Due to changing lifestyle, a number of disorders like obesity and degenerative joint diseases are affecting the masses across the globe. These factors directly or indirectly develop cartilage injuries; and lead to decline in the productivity of the working population, which ultimately causes some degree of disability. Therefore, increasing epidemiology of such diseases require effective treatment options, generating significant demand for regenerative medicine used to restore damaged cartilage.

According to RNCOS new release, "Global Cartilage Repair and Regeneration Market, by Treatment Modalities (Cell-Based Approach, Non-Cell-Based Approach), by Procedure Type, by Application Outlook 2022 ", the industry is expanding at a fast pace. As per RNCOS report, the Cartilage Repair and Regeneration market is anticipated to witness a high double digit growth during the forecasted period (2016-2022). This report provides a detailed analysis of the current and future market scenario of the global Cartilage Repair and Regeneration market. The report provides insight about the major factors affecting growth, latest innovations, market segmentation, and competitive landscape.

The report segments the market on the basis of the treatment modalities, procedure type, applications, and geography, with the future forecasts on all prominent segments of the industry till 2022.

Based on treatment modality, the cell based approaches segment accounts for the largest market share in the overall cartilage repair and regeneration market, due to long-term results of these therapies.

In terms of procedure type, microfracture and ACI are the most common procedure observed amongst all the types of cartilage repair procedure. Furthermore, in terms of application, the hyaline cartilage repair and regeneration market accounts for the largest share in 2016. It is also expected to be the fastest growing application segment in the cartilage repair and regeneration market. The large share and high growth of this segment can be attributed to the high prevalence of cartilage damage in hyaline cartilage.

Based on geography, the report divides the market into North America, Europe, and Asia-Pacific. In 2016, North America holds the major share in the market. However, the Asia-Pacific region is slated to witness the highest growth in the forecasted period. The growth of the Asia-Pacific market is driven by improving healthcare facilities, rising awareness, increasing prevalence of rheumatoid and osteoarthritis, and increasing government initiatives in this region.

The report finally covers the competitive analysis of the key market players, in terms of their market share and their product offerings. The key vendors dominating the market space are Stryker Corp., Zimmer Biomet Holdings Inc., Smith & Nephew Plc, DePuy Synthes, Inc., etc. The competitive analysis is done at each player level, including their recent developments. To provide a thorough understanding of each player's business model, the player's current and historical financials have been analyzed. Thus, the report provides comprehensive analysis of cartilage repair & regeneration technology, which will enable investors to design suitable business strategies to target this market.

TABLE OF CONTENTS

1. Analyst View

2. Research Methodology

3. Cartilage Repair-Overview

4. Market Dynamics

  • 4.1 Drivers
    • 4.1.1 Growing Incidences of Chondrodystrophies leading to Cartilage Injuries
    • 4.1.2 Rising Incidences of Orthopedic Diseases
    • 4.1.3 Surge in Sports Injuries
    • 4.1.4 Growing Geriatric Popuation
    • 4.1.5 Rising Prevalence of Obesity
    • 4.1.6 Technological Advancements
  • 4.2 Challenges
    • 4.2.1 Limited Health Insurance Coverage in Developing Countries
    • 4.2.2 High Cost of Knee Cartilage Repair Surgeries
    • 4.2.3 Complexity of Cartilage Repair Surgeries
  • 4.3 Opportunities
    • 4.3.1 Significant US Market Opportunity Due to Unsatisfactory First Line Therapies
    • 4.3.2 Emerging Economies to Offer Sustained Growth Opportunities
    • 4.3.3 Increased R&D Spending for Advancements in Knee Cartilage Repair
    • 4.3.4 Use of Bioactive Growth Factors
    • 4.3.5 3D Printing

5. Global Cartilage Repair and Regeneration Market Outlook 2022

6. Cartilage Repair and Regeneration Market, By Treatment Modalities

  • 6.1 Cell-Based Approach
  • 6.2 Non-Cell-Based Approach

7. Global Cartilage Repair and Regeneration Market, By Procedure Type

  • 7.1 Autologous Chondrocyte Transplantation
  • 7.2 Cell-Based Cartilage Resurfacing
  • 7.3 Microfracture
  • 7.4 Osteochondral Allograft
  • 7.5 Others

8. Global Cartilage Repair and Regeneration Market, By Application

  • 8.1 Hyaline Cartilage Repair and Regeneration
  • 8.2 Elastic Cartilage Repair and Regeneration
  • 8.3 Fibrous Cartilage Repair and Regeneration

9. Global Cartilage Repair and Regeneration Market, By Geography

  • 9.1 North America
  • 9.2 Europe
  • 9.3 Asia-Pacific

10. Regulatory Landscape

11. Trends & Developments

  • 11.1 Cost Effectiveness Promoting Interest in One-Step Surgery
  • 11.2 Bioactive Signals that Enhance Cartilage Repair
  • 11.3 Gene Therapy for Cartilage Repair
  • 11.4 Mesenchymal Stem Cells

12. Competitive Landscape

  • 12.1 Market Share of Key Players
  • 12.2 Comparative Analysis of Products

13. Key Players Analysis

  • 13.1 Stryker Corporation
  • 13.2 B. Braun Melsungen AG
  • 13.3 Zimmer Biomet Holdings, Inc.
  • 13.4 Smith & Nephew plc
  • 13.5 DePuy Synthes, Inc. (A Subsidiary of Johnson & Johnson)
  • 13.6 Arthrex, Inc.
  • 13.7 Osiris Therapeutics, Inc.
  • 13.8 Vericel Corporation
  • 13.9 RTI Surgical, Inc.
  • 13.10 CONMED Corporation
  • 13.11 Anika Therapeutics, Inc.

14. The Future of Cartilage Repair

List of Figures

  • Figure 4-1: Global - Population above 60 Years (Billion), 2015 & 2050
  • Figure 5-1: Global - Cartilage Repair and Regeneration Market (Million US$), 2016-2022
  • Figure 6-1: Global - Cartilage Repair and Regeneration Market by Treatment Modalitites (%), 2016
  • Figure 6-2: Global - Cell-Based Approach Market for Cartilage Repair and Regeneration (Million US$), 2016-2022
  • Figure 6-3: Global - Non-Cell-Based Approach Market for Cartilage Repair and Regeneration (Million US$), 2016-2022
  • Figure 7-1: Global - Cartilage Repair and Regeneration Market by Procedure Type (%), 2016
  • Figure 7-2: Global - Autologous Chondrocyte Transplantation Market (Million US$), 2016-2022
  • Figure 7-3: Global - Cell-Based Cartilage Resurfacing Market (Million US$), 2016-2022
  • Figure 7-4: Global - Microfracture Market (Million US$), 2016-2022
  • Figure 7-5: Global - Osteochondral Allograft Market (Million US$), 2016-2022
  • Figure 7-6: Global - Others Market (Million US$), 2016-2022
  • Figure 8-1: Global - Cartilage Repair and Regeneration Market by Application (%), 2016
  • Figure 8-2: Global - Hyaline Cartilage Repair and Regeneration Market (Million US$), 2016-2022
  • Figure 8-3: Global - Elastic Cartilage Repair and Regeneration Market (Million US$), 2016-2022
  • Figure 8-4: Global - Fibrous Cartilage Repair and Regeneration Market (Million US$), 2016-2022
  • Figure 9-1: Global - Cartilage Repair and Regeneration Market by Geography (%), 2016
  • Figure 9-2: North America - Cartilage Repair and Regeneration Market (Million US$), 2016-2022
  • Figure 9-3: Europe - Cartilage Repair and Regeneration Market (Million US$), 2016-2022
  • Figure 9-4: Asia-Pacific - Cartilage Repair and Regeneration Market (Million US$), 2016-2022
  • Figure 12-1: Global - Share of Major Players in Cartilage Repair and Regeneration Market (%), 2016
  • Figure 13-1: Stryker Corporation - Breakup of Net Sales by Region (%), 2016
  • Figure 13-2: B. Braun Melsungen AG - Breakup of Net Sales by Region (%), 2015
  • Figure 13-3: Zimmer Biomet Holdings, Inc. - Breakup of Net Sales by Region (%), 2016
  • Figure 13-4: Smith & Nephew plc - Breakup of Revenue by Region (%), 2016
  • Figure 13-5: Johnson & Johnson - Breakup of Revenue by Region (%), 2015
  • Figure 13-6: CONMED Corporation - Breakup of Revenue by Region (%), 2015
  • Figure 13-7: Anika Therapeutics, Inc. - Breakup of Revenue by Region (%), 2015

List of Tables

  • Table 9-1: North America - Clinical Trials for Cartilage Damage
  • Table 9-2: Europe - Clinical Trials for Cartilage Damage
  • Table 9-3: Asia-Pacific - Clinical Trials for Cartilage Damage
  • Table 12-1: Comparison of Major Cartilage Repair and Regeneration Products
  • Table 13-1: Stryker Corporation - Key Financials (Million US$), 2014-2016
  • Table 13-2: Stryker Corporation - Net Sales by Business Segment (Million US$), 2014-2016
  • Table 13-3: Stryker Corporation - Orthopaedics Net Sales by Product Segment (Million US$), 2014-2016
  • Table 13-4: Stryker Corporation - Product Portfolio for Cartilage Repair & Regeneration Market
  • Table 13-5: B. Braun Melsungen AG - Key Financials (Million US$), 2013-2015
  • Table 13-6: B. Braun Melsungen AG - Net Sales by Product Segment (Million US$), 2013-2015
  • Table 13-7: B. Braun Melsungen AG - Product Portfolio for Cartilage Repair & Regeneration
  • Table 13-8: Zimmer Biomet Holdings, Inc. - Key Financials (Million US$), 2014-2016
  • Table 13-9: Zimmer Biomet Holdings, Inc. - Net Sales by Product Segment (Million US$), 2014-2016
  • Table 13-10: Zimmer Biomet Holdings, Inc. - Product Portfolio for Cartilage Repair & Regeneration Market
  • Table 13-11: Smith & Nephew plc - Key Financials (Million US$), 2014-2016
  • Table 13-12: Smith & Nephew plc - Revenue by Product Segment (Million US$), 2014-2016
  • Table 13-13: Smith & Nephew plc - Product Portfolio for Cartilage Repair & Regeneration Market
  • Table 13-14: Johnson & Johnson - Key Financials (Million US$), 2013-2015
  • Table 13-15: Johnson & Johnson - Revenue by Product Segment (Million US$), 2013-2015
  • Table 13-16: Johnson & Johnson - Medical Devices Revenue by Product Segment (Million US$), 2013-2015
  • Table 13-17: Johnson & Johnson - Product Portfolio for Cartilage Repair & Regeneration Market
  • Table 13-18: Osiris Therapeutics, Inc. - Key Financials (Million US$), 2012-2014
  • Table 13-19: Osiris Therapeutics, Inc. - Product Portfolio for Cartilage Repair & Regeneration Market
  • Table 13-20: Vericel Corporation - Key Financials (Million US$), 2013-2015
  • Table 13-21: Vericel Corporation - Revenue by Product (Million US$), 2013-2015
  • Table 13-22: Vericel Corporation - Product Portfolio for Cartilage Repair & Regeneration Market
  • Table 13-23: RTI Surgical, Inc. - Product Portfolio for Cartilage Repair & Regeneration Market
  • Table 13-24: CONMED Corporation - Key Financials (Million US$), 2013-2015
  • Table 13-25: CONMED Corporation - Revenue by Product Segment (Million US$), 2013-2015
  • Table 13-26: CONMED Corporation - Product Portfolio for Cartilage Repair & Regeneration Market
  • Table 13-27: Anika Therapeutics, Inc. - Key Financials (Million US$), 2013-2015
  • Table 13-28: Anika Therapeutics, Inc. - Revenue by Product Segment (Million US$), 2013-2015
  • Table 13-29: Anika Therapeutics, Inc. - Product Portfolio for Cartilage Repair & Regeneration Market